Compare MNDY & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MNDY | DNLI |
|---|---|---|
| Founded | 2012 | 2013 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.7B |
| IPO Year | 2021 | 2017 |
| Metric | MNDY | DNLI |
|---|---|---|
| Price | $82.78 | $22.71 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 26 | 14 |
| Target Price | ★ $167.65 | $34.33 |
| AVG Volume (30 Days) | 928.5K | ★ 1.8M |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $20.70 | N/A |
| Revenue Next Year | $16.48 | $408.85 |
| P/E Ratio | $34.38 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $57.50 | $12.58 |
| 52 Week High | $296.94 | $27.30 |
| Indicator | MNDY | DNLI |
|---|---|---|
| Relative Strength Index (RSI) | 55.33 | 42.79 |
| Support Level | $67.84 | $18.27 |
| Resistance Level | $88.48 | $23.27 |
| Average True Range (ATR) | 4.12 | 1.38 |
| MACD | 1.07 | -0.30 |
| Stochastic Oscillator | 76.26 | 11.57 |
Monday.com Ltd is an artificial intelligence work platform that runs and orchestrates the core of all work. The platform democratizes access to software, including AI, enabling organizations to easily build applications and work management tools that fit their needs. The cloud-based platform is a no-code and low-code framework built from modular building blocks that are simple enough for anyone to use, yet powerful enough to drive core business across any organization. The platform also integrates with other systems and applications, creating a connective layer for organizations that links departments and bridges information silos. In addition to the core products, it introduced four core Al work capabilities: monday sidekick, monday vibe, monday agents, and workflows.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.